Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1073/pnas.1421420112 http://scihub22266oqcxt.onion/10.1073/pnas.1421420112 C4291642!4291642!25535367     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Proc+Natl+Acad+Sci+U+S+A 2015 ; 112 (1): 285-90 Nephropedia Template TP {{tp|p=25535367|t=2015. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome |pdf=|usr=}}{{25535367}} gab.com Text A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome JO: Proc Natl Acad Sci U S A http://www.kidney.de/pget.php?&tw=1&pmid=25535367 #FOAvip Obesity and associated metabolic disorders (e.g., cardiovascular disease and type 2 diabetes) are major public health concerns. These disorders result, in part, from hormonal dysregulation, particularly of glucocorticoids (GCs; central regulators of metabolism and adipogenesis). The specific mechanisms by which GCs modulate these processes remain largely unknown, but GCs increase production of endocannabinoids?potent central and peripheral regulators of appetite, energy balance, and metabolism. Our results show that sustained exposure to GCs produces obesity and metabolic syndrome through a peripheral endocannabinoid mechanism. These data further our understanding of the role of endocannabinoid signaling to promote not only diet-induced, but also, hormonal-mediated obesity and support the argument that peripheral blockade of endocannabinoid signaling could be a potential treatment for obese conditions. Twit Text FOAVip A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome ????Proc Natl Acad Sci U S A http://www.kidney.de/pget.php?&tw=1&pmid=25535367 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25535367 #FOAvip English Wikipedia <ref>{{Cite pmid|25535367}}</ref> A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome #MMPMID25535367 Bowles NP; Karatsoreos IN; Li X; Vemuri VK; Wood JA; Li Z; Tamashiro KLK; Schwartz GJ; Makriyannis AM; Kunos G; Hillard CJ; McEwen BS; Hill MN Proc Natl Acad Sci U S A 2015[Jan]; 112 (1): 285-90 PMID25535367show ga Obesity and associated metabolic disorders (e.g., cardiovascular disease and type 2 diabetes) are major public health concerns. These disorders result, in part, from hormonal dysregulation, particularly of glucocorticoids (GCs; central regulators of metabolism and adipogenesis). The specific mechanisms by which GCs modulate these processes remain largely unknown, but GCs increase production of endocannabinoids?potent central and peripheral regulators of appetite, energy balance, and metabolism. Our results show that sustained exposure to GCs produces obesity and metabolic syndrome through a peripheral endocannabinoid mechanism. These data further our understanding of the role of endocannabinoid signaling to promote not only diet-induced, but also, hormonal-mediated obesity and support the argument that peripheral blockade of endocannabinoid signaling could be a potential treatment for obese conditions. äA peripheral endocannabinoid mechanism contributes to glucocorticoid-m(epmc).pdf DeepDyve Pubget Overpricing